Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor for optic nerve injury
CTR20132891Phase 3Active
- Sponsor
- Xiamen Beida Zhilu Biotechnology
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of mouse nerve growth factor in Optic neuropathies, sponsored by Xiamen Beida Zhilu Biotechnology. Started Feb 2014; status: active.
02
Drugs
mouse nerve growth factor
03
Conditions
Optic neuropathies
Beyond the preview
Go deeper on CTR20132891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132891.